{
  "slug": "fortrea",
  "name": "Fortrea",
  "description": "Fortrea is a global contract research organization (CRO) that provides comprehensive Phase I through IV study management, clinical pharmacology, and market access solutions to biopharmaceutical and MedTech companies worldwide. Spun off from Labcorp, it leverages over 30 years of legacy expertise to offer flexible, scalable, and innovative solutions aimed at accelerating drug development and bringing life-changing therapies to patients faster.",
  "url": "https://optimly.ai/brand/fortrea",
  "websiteUrl": null,
  "logoUrl": "https://logo.clearbit.com/https://www.fortrea.com/",
  "baiScore": 55,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Challenger",
  "archetype_status": "active",
  "category": "Healthcare Services",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-02T00:03:00.861Z",
  "verifiedVitals": {
    "website": "https://www.fortrea.com",
    "founded": "2023",
    "headquarters": "Princeton, New Jersey, USA",
    "pricing_model": "Customized project-based and Functional Service Provider (FSP) models, emphasizing flexible and scalable delivery aligned to client needs.",
    "core_products": "Phase I-IV study management, Clinical Pharmacology Services, Market Access Strategy/Consulting, Pharmacovigilance/Safety Services, Regulatory Strategy/Consulting, Functional Service Provider (FSP) Solutions, Fortrea Intelligent Technology™, Integrated Cell Therapy Development Solutions.",
    "key_differentiator": "Leverages 30+ years of legacy experience with a renewed focus on innovation to redefine clinical trial delivery. Offers flexible, scalable, and integrated global CRO services, site connections, and strategic collaborations (e.g., cell therapy) to accelerate decision-making and bring treatments to market faster.",
    "target_markets": "Biopharma companies, MedTech companies, Innovators in cell-based therapies and viral vectors.",
    "employee_count": "Not specified in the provided context.",
    "funding_stage": "Publicly traded (spun off from a major corporation).",
    "subcategory": "Clinical Research Organization (CRO)"
  },
  "intentTags": {
    "problemIntents": [
      "In-house Clinical Trial Management: Biopharma or MedTech companies could manage clinical trials and regulatory processes entirely with their internal teams, requiring significant internal resources, e",
      "Delay or Halt Drug Development: Without external CRO support, companies might face significant delays or be unable to conduct clinical trials, leading to delayed or halted development of new therapies"
    ],
    "solutionIntents": [
      "clinical research organization Fortrea",
      "Fortrea CRO services",
      "Pharmacovigilance Fortrea",
      "cell therapy development Fortrea",
      "Fortrea market access solutions",
      "Specialized Biostatistics & Data Management Software: Companies might use specific software solutions for data collection (EDC), statistical analysis, and regulatory submission, but these tools don't "
    ],
    "evaluationIntents": []
  },
  "timestamp": 1785874538008
}